Paul R. Kirchgraber, CEO, Covance Drug Development: Labcorp Holdings LH Sell · Filed 23/02/23

Trade details

Type: Insider sale
Amount: $2,004,640
Shares · price: 8,000 sh · $250.58 a share
Held after: 9,069 sh
Stock: Labcorp Holdings LH
Person: Paul R. KirchgraberCEO, Covance Drug Development
Trade date: 23/02/21
Filed: 23/02/23
Days to filing: 2 days

Sold 46.9% of holdings

Share of holding sold: 46.9%

Labcorp Holdings trades, last 26 weeks

What else happened in Labcorp Holdings around then

Filed or reported within 30 days of the trade day · 23/01/22~23/03/23

Paul R. Kirchgraber's recent trades

Paul R. KirchgraberCEO, Covance Drug Development
SellLabcorp Holdings
Sell
Labcorp Holdings
LH
$932.7K
4,300 sh
$932.7K
Filed 23/05/23
Traded 23/05/19